{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:20:52Z","timestamp":1778145652235,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174115"],"award-info":[{"award-number":["82174115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metanephric mesenchymal cells (MMCs) hold therapeutic potential for acute kidney injury (AKI), but their efficacy is limited, and the mechanisms underlying their action remain unclear. This study aimed to investigate whether catalpol-pretreated MMCs (MMCs-cata) could enhance the efficacy of AKI treatment by regulating key signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An AKI model was established in C57BL6 mice via intraperitoneal injection of cisplatin, and the therapeutic effects of MMCs-cata were compared with those of untreated MMCs. RNA-Seq was performed to analyze differentially expressed genes, Western blotting and ELISA were used to measure VEGF-A levels in MMC-cata and the supernatants. An in vitro model of cisplatin-induced renal tubular epithelial cell injury was developed to investigate the signaling pathways upstream and downstream of VEGF-A. The role of VEGF-A\/VEGFR2 was confirmed through experiments involving gene silencing, neutralizing antibodies, and VEGFR2 blockade. Additionally, molecular docking simulations and Western blotting were performed to explore the effects of catalpol on the Wnt signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MMCs-cata significantly improved renal function in AKI model mice by suppressing inflammation, oxidative stress, and necroptosis. RNA-Seq, Western blotting and ELISA revealed the activation of VEGF-related genes in MMCs-cata along with elevated intracellular and supernatant VEGF-A levels. In both the in vivo and in vitro models, silencing VEGF-A in MMCs-cata, neutralizing VEGF-A in the supernatant, or blocking VEGFR2 in tubular epithelial cells abolished the protective effects of MMCs-cata, while exogenous VEGF-A supplementation alone exerted protective effects. Mechanistic studies indicated that MMCs-cata activated the p38 pathway and suppressed the STAT3 pathway. Molecular docking and Western blotting confirmed that catalpol binds to Wnt3A, activating the canonical Wnt pathway to drive VEGF-A secretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Catalpol pretreatment enhances the therapeutic efficacy of MMCs by activating the canonical Wnt pathway to promote VEGF-A secretion. VEGF-A interacts with VEGFR2 on renal tubular epithelial cells, likely through both p38 pathway activation and STAT3 pathway inhibition, thereby suppressing inflammation, oxidative stress, and necroptosis to alleviate AKI. This study provides novel insights into the integration of traditional Chinese medicine components with stem cell therapy for AKI management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-026-04914-9","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:04:34Z","timestamp":1774688674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pretreatment of metanephric mesenchymal cells with catalpol mitigates acute kidney injury through VEGF-A secretion via multiple mechanisms"],"prefix":"10.1186","volume":"17","author":[{"given":"Pengcheng","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenkai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"9843","key":"4914_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756\u201366.","journal-title":"Lancet"},{"key":"4914_CR2","doi-asserted-by":"crossref","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52.","DOI":"10.1038\/s41572-021-00284-z"},{"issue":"12","key":"4914_CR3","doi-asserted-by":"publisher","first-page":"9681","DOI":"10.3390\/curroncol29120760","volume":"29","author":"J Halka","year":"2022","unstructured":"Halka J, Spaleniak S, Kade G, Antosiewicz S, Sigorski D. The nephrotoxicity of drugs used in causal oncological therapies. Curr Oncol. 2022;29(12):9681\u201394.","journal-title":"Curr Oncol"},{"issue":"12","key":"4914_CR4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","volume":"42","author":"CY Fang","year":"2021","unstructured":"Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, et al. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951\u201369.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"4914_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2215\/CJN.15611219","volume":"15","author":"KD Liu","year":"2020","unstructured":"Liu KD, Goldstein SL, Vijayan A, Parikh CR, Kashani K, Okusa MD, et al. AKI!now initiative: recommendations for awareness, recognition, and management of AKI. Clin J Am Soc Nephrol. 2020;15(12):1838\u201347.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4914_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101970","volume":"79","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wu Y, Liu Y, Zhang Y, Yang X, Gao Y, et al. A novel type of mesenchymal stem cells derived from bovine metanephric mesenchyme. Tissue Cell. 2022;79:101970.","journal-title":"Tissue Cell"},{"issue":"9","key":"4914_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s11655-024-3761-1","volume":"30","author":"PC Ji","year":"2024","unstructured":"Ji PC, Xie YS, Guo WK, Fu B, Chen XM. P38 signaling mediates Naringin-induced osteogenic differentiation of Porcine metanephric mesenchymal cells. Chin J Integr Med. 2024;30(9):818\u201325.","journal-title":"Chin J Integr Med"},{"issue":"2","key":"4914_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12519-012-0353-5","volume":"8","author":"L Liu","year":"2012","unstructured":"Liu L, Chen D, Yi ZW, Liu XH, Wu XC, Dang XQ, et al. Nephroprotective effects of subcapsular transplantation of metanephric mesenchymal cells on gentamicin-induced acute tubular necrosis in rats. World J Pediatr. 2012;8(2):156\u201363.","journal-title":"World J Pediatr"},{"issue":"8","key":"4914_CR9","first-page":"534","volume":"88","author":"JF Zhou","year":"2008","unstructured":"Zhou JF, Yuan FH, Li N, Yu J, Zhang YQ, Hou WP. [Protective effects of metanephric mesenchymal cells on acute renal tubular damage: experiment with rats]. Zhonghua Yi Xue Za Zhi. 2008;88(8):534\u20139.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"4914_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03351-2","volume":"14","author":"Z Fu","year":"2023","unstructured":"Fu Z, Zhang Y, Geng X, Chi K, Liu C, Song C, et al. Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury. Stem Cell Res Ther. 2023;14(1):116.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4914_CR11","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1007\/s12035-018-1305-4","volume":"56","author":"E Abati","year":"2019","unstructured":"Abati E, Bresolin N, Comi GP, Corti S. Preconditioning and cellular engineering to increase the survival of transplanted neural stem cells for motor neuron disease therapy. Mol Neurobiol. 2019;56(5):3356\u201367.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4914_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01671-1","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Ji Y, Hong H, Geng X, Zhang K, et al. All-trans retinoic acid pretreatment of mesenchymal stem cells enhances the therapeutic effect on acute kidney injury. Cell Commun Signal. 2024;22(1):291.","journal-title":"Cell Commun Signal"},{"issue":"33","key":"4914_CR13","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.2174\/0929867326666190620103813","volume":"26","author":"LQ Zhang","year":"2019","unstructured":"Zhang LQ, Chen KX, Li YM. Bioactivities of natural catalpol derivatives. Curr Med Chem. 2019;26(33):6149\u201373.","journal-title":"Curr Med Chem"},{"issue":"2","key":"4914_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11064-022-03796-6","volume":"48","author":"H Ni","year":"2023","unstructured":"Ni H, Rui Q, Kan X, Gao R, Zhang L, Zhang B. Catalpol ameliorates oxidative stress and neuroinflammation after traumatic brain injury in rats. Neurochem Res. 2023;48(2):681\u201395.","journal-title":"Neurochem Res"},{"key":"4914_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192694","volume":"14","author":"Z Fu","year":"2023","unstructured":"Fu Z, Su X, Zhou Q, Feng H, Ding R, Ye H. Protective effects and possible mechanisms of catalpol against diabetic nephropathy in animal models: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1192694.","journal-title":"Front Pharmacol"},{"key":"4914_CR16","volume":"2022","author":"H Chen","year":"2022","unstructured":"Chen H, Deng C, Meng Z, Meng S. Effects of catalpol on Alzheimer\u2019s disease and its mechanisms. Evid Based Complement Alternat Med. 2022;2022:2794243.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"4914_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-024-04366-9","volume":"24","author":"Z Li","year":"2024","unstructured":"Li Z, He R, Liu J, Jin X, Jiang B, Lao Y, et al. JianPiYiShen formula prevents cisplatin-induced acute kidney injury in mice by improving necroptosis through MAPK pathway. BMC Complement Med Ther. 2024;24(1):101.","journal-title":"BMC Complement Med Ther"},{"key":"4914_CR18","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/DDDT.S433994","volume":"17","author":"X Jin","year":"2023","unstructured":"Jin X, He R, Lin Y, Liu J, Wang Y, Li Z, et al. Shenshuaifu granule attenuates acute kidney injury by inhibiting ferroptosis mediated by p53\/SLC7A11\/GPX4 pathway. Drug Des Devel Ther. 2023;17:3363\u201383.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"4914_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/mmr.2014.1883","volume":"9","author":"Z Gao","year":"2014","unstructured":"Gao Z, Liu G, Hu Z, Li X, Yang X, Jiang B, et al. Grape seed proanthocyanidin extract protects from cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis. Mol Med Rep. 2014;9(3):801\u20137.","journal-title":"Mol Med Rep"},{"issue":"4","key":"4914_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.kint.2017.08.030","volume":"93","author":"M Bai","year":"2018","unstructured":"Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai G, et al. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2\/PGE2 pathway. Kidney Int. 2018;93(4):814\u201325.","journal-title":"Kidney Int"},{"issue":"9","key":"4914_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41401-023-01070-1","volume":"44","author":"MJ Huang","year":"2023","unstructured":"Huang MJ, Ji YW, Chen JW, Li D, Zhou T, Qi P, et al. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis. Acta Pharmacol Sin. 2023;44(9):1815\u201325.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4914_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05155-1","volume":"22","author":"M Guo","year":"2024","unstructured":"Guo M, Zhang J, Han J, Hu Y, Ni H, Yuan J, et al. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis. J Transl Med. 2024;22(1):419.","journal-title":"J Transl Med"},{"issue":"1","key":"4914_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02019-4","volume":"9","author":"Y Bai","year":"2024","unstructured":"Bai Y, Chen L, Guo F, Zhang J, Hu J, Tao X, et al. EphrinB2-mediated CDK5\/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation. Signal Transduct Target Ther. 2024;9(1):326.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4914_CR24","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.7150\/thno.73426","volume":"12","author":"JW Chen","year":"2022","unstructured":"Chen JW, Huang MJ, Chen XN, Wu LL, Li QG, Hong Q, et al. Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9(+) renal tubular cells. Theranostics. 2022;12(12):5434\u201350.","journal-title":"Theranostics"},{"issue":"25","key":"4914_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414587","volume":"12","author":"C Xuan","year":"2025","unstructured":"Xuan C, Chen D, Zhang S, Li C, Fang Q, Chen D, et al. Isoquercitrin alleviates diabetic nephropathy by inhibiting STAT3 phosphorylation and dimerization. Adv Sci Weinh. 2025;12(25):e2414587.","journal-title":"Adv Sci Weinh"},{"issue":"11","key":"4914_CR26","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1681\/ASN.2014080741","volume":"26","author":"Y Xu","year":"2015","unstructured":"Xu Y, Ma H, Shao J, Wu J, Zhou L, Zhang Z, et al. A role for tubular necroptosis in Cisplatin-induced AKI. J Am Soc Nephrol. 2015;26(11):2647\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"4914_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2023.07.022","volume":"207","author":"S Rius-Perez","year":"2023","unstructured":"Rius-Perez S. P53 at the crossroad between mitochondrial reactive oxygen species and necroptosis. Free Radic Biol Med. 2023;207:183\u201393.","journal-title":"Free Radic Biol Med"},{"key":"4914_CR28","doi-asserted-by":"crossref","unstructured":"Zhang D, Jiang H, Yang X, Zheng S, Li Y, Liu S, et al. Traditional Chinese medicine and renal regeneration: experimental evidence and future perspectives. Chin Med. 2024;19(1):77.","DOI":"10.1186\/s13020-024-00935-9"},{"issue":"8","key":"4914_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.ki.5002784","volume":"73","author":"R Nishinakamura","year":"2008","unstructured":"Nishinakamura R. Stem cells in the embryonic kidney. Kidney Int. 2008;73(8):913\u20137.","journal-title":"Kidney Int"},{"issue":"6","key":"4914_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.kint.2019.12.019","volume":"97","author":"B Fazekas","year":"2020","unstructured":"Fazekas B, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade. Kidney Int. 2020;97(6):1130\u201340.","journal-title":"Kidney Int"},{"key":"4914_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041232","author":"Y Itatani","year":"2018","unstructured":"Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19041232.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4914_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248\u201364.","journal-title":"Cell"},{"issue":"2","key":"4914_CR33","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455\u201367.","journal-title":"Rom J Morphol Embryol"},{"issue":"7","key":"4914_CR34","doi-asserted-by":"publisher","first-page":"e0269818","DOI":"10.1371\/journal.pone.0269818","volume":"17","author":"J Sarkar","year":"2022","unstructured":"Sarkar J, Luo Y, Zhou Q, Ivakhnitskaia E, Lara D, Katz E, et al. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types. PLoS One. 2022;17(7):e0269818.","journal-title":"PLoS One"},{"issue":"2","key":"4914_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1523-1755.2005.67101.x","volume":"67","author":"G Villegas","year":"2005","unstructured":"Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67(2):449\u201357.","journal-title":"Kidney Int"},{"issue":"6","key":"4914_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40259-023-00621-6","volume":"37","author":"YC Tsao","year":"2023","unstructured":"Tsao YC, Chen TY, Wang LA, Lee CC, Lee WA, Hsu SM, et al. Acute kidney injury from intravitreal Anti-vascular endothelial growth factor drugs: A systematic review and Meta-analysis of randomized controlled trials. BioDrugs. 2023;37(6):843\u201354.","journal-title":"BioDrugs"},{"issue":"3\u20134","key":"4914_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000353233","volume":"123","author":"Y Gheisari","year":"2013","unstructured":"Gheisari Y, Ahmadbeigi N, Aghaee-Bakhtiari SH, Nassiri SM, Amanpour S, Azadmanesh K, et al. Human unrestricted somatic stem cell administration fails to protect nude mice from cisplatin-induced acute kidney injury. Nephron Exp Nephrol. 2013;123(3\u20134):11\u201321.","journal-title":"Nephron Exp Nephrol"},{"issue":"5","key":"4914_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12012-018-9460-4","volume":"18","author":"X Ju","year":"2018","unstructured":"Ju X, Xue D, Wang T, Ge B, Zhang Y, Li Z. Catalpol promotes the survival and VEGF secretion of bone marrow-derived stem cells and their role in myocardial repair after myocardial infarction in rats. Cardiovasc Toxicol. 2018;18(5):471\u201381.","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"4914_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jgg.2014.11.007","volume":"42","author":"Z Li","year":"2015","unstructured":"Li Z, Liu S, Cai Y. EGFR\/MAPK signaling regulates the proliferation of drosophila renal and nephric stem cells. J Genet Genomics. 2015;42(1):9\u201320.","journal-title":"J Genet Genomics"},{"key":"4914_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122476","volume":"341","author":"C Yu","year":"2024","unstructured":"Yu C, Zhang J, Pei J, Luo J, Hong Y, Tian X, et al. IL-13 alleviates acute kidney injury and promotes regeneration via activating the JAK-STAT signaling pathway in a rat kidney transplantation model. Life Sci. 2024;341:122476.","journal-title":"Life Sci"},{"issue":"6","key":"4914_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06756-w","volume":"15","author":"Y Cui","year":"2024","unstructured":"Cui Y, Chen C, Tang Z, Yuan W, Yue K, Cui P, et al. TREM2 deficiency aggravates renal injury by promoting macrophage apoptosis and polarization via the JAK-STAT pathway in mice. Cell Death Dis. 2024;15(6):401.","journal-title":"Cell Death Dis"},{"key":"4914_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176406","volume":"968","author":"J Lin","year":"2024","unstructured":"Lin J, Deng L, Qi A, Jiang H, Xu D, Zheng Y, et al. Catalpol alleviates hypoxia ischemia-induced brain damage by inhibiting ferroptosis through the PI3K\/NRF2\/system Xc-\/GPX4 axis in neonatal rats. Eur J Pharmacol. 2024;968:176406.","journal-title":"Eur J Pharmacol"},{"key":"4914_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.716125","volume":"12","author":"L He","year":"2021","unstructured":"He L, Zhao R, Wang Y, Liu H, Wang X. Research progress on catalpol as treatment for atherosclerosis. Front Pharmacol. 2021;12:716125.","journal-title":"Front Pharmacol"},{"key":"4914_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24183302","author":"Y Bai","year":"2019","unstructured":"Bai Y, Zhu R, Tian Y, Li R, Chen B, Zhang H, et al. Catalpol in diabetes and its complications: a review of pharmacology, pharmacokinetics, and safety. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24183302.","journal-title":"Molecules"},{"issue":"7","key":"4914_CR45","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/ddr.22096","volume":"84","author":"J Liu","year":"2023","unstructured":"Liu J, Liu S, Yu M, Li J, Xie Z, Gao B, et al. Anti-inflammatory effect and mechanism of catalpol in various inflammatory diseases. Drug Dev Res. 2023;84(7):1376\u201394.","journal-title":"Drug Dev Res"},{"issue":"6","key":"4914_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.humimm.2022.04.003","volume":"83","author":"H Saoud","year":"2022","unstructured":"Saoud H, Aflouk Y, Ben Afia A, Gaha L, Bel Hadj Jrad B. Association of VEGF-A and KDR polymorphisms with the development of schizophrenia. Hum Immunol. 2022;83(6):528\u201337.","journal-title":"Hum Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04914-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04914-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04914-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:03:26Z","timestamp":1778144606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04914-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4914"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04914-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were conducted in line with the ARRIVE guidelines 2.0. All animal experiments were performed under ethical supervision and approved by the Institutional Animal Care and Use Committee of the Chinese PLA General Hospital in 2024 (Title research: Effects of Catalpol and the Injured Microenvironment on Epithelial Transdifferentiation and Renal Tubular Repair of Metanephric Mesenchymal Cells. No. 2024-X20-97).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}